Lisa Kearns, MS, MA
Senior Research Associate, NYU School of Medicine’s Division of Medical Ethics
As a member of the Division’s Working Group on Compassionate Use and Pre-Approval Access, she has spoken and published extensively on state and federal “right to try” legislation and has served as an expert on the subject for two external organizations.
She has been involved with the Compassionate Use Advisory Committee since its inception. CompAC is a panel of internationally recognized medical experts, bioethicists, and patient representatives formed at the request of Janssen, the pharmaceutical arm of Johnson & Johnson, to provide guidance on how to fairly and transparently allocate a scarce investigational drug to patients outside of clinical trials.
She is also the deputy chair of a new CompAC panel. Other areas of interest include public health ethics, research integrity, and ethical issues of the federal Precision Medicine Initiative. She has an MA in philosophy from UNC Chapel Hill and an MS in bioethics from Columbia.